Status:
UNKNOWN
Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis
Lead Sponsor:
Ondine Research Laboratories
Conditions:
Periodontitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is to determine whether scaling and root planing (SRP) followed by photodynamic disinfection results in improved outcomes that persist over time in adults with chronic periodontitis when co...
Detailed Description
Extensive research has shown that lethal photosensitization with low levels of laser light is an effective method of killing numerous types of organisms. This therapy avoids the use of antibiotics alo...
Eligibility Criteria
Inclusion
- Adult male or female over the age of 18
- Having been diagnosed with chronic periodontitis
- \>18 fully erupted teeth
- Has had no periodontal instrumentation in the four months prior to initiation of study treatment
- Subject has at least 4 sites with pocket depth of 6-9 mm in at least two quadrants of the mouth.
- Subject is willing and able to return for treatment and evaluation procedures scheduled throughout the course of this clinical study
- The subject is capable of giving informed consent
- Subject is willing to sign a consent form
Exclusion
- Is pregnant or nursing or who plans to become pregnant in the next 4 months
- Having significant liver disease by subject report
- Having an active malignancy of any type by subject report
- Having chronic disease or diminished mental capacity that would mitigate the ability to comply with the protocol
- Having any significant disease (either acute or chronic) or who is taking medication with concomitant oral manifestations that in the opinion of the investigator would interfere with evaluation of safety or efficacy of PerioWave®
- Having an active periapical abscess or periodontal abscess or a history of acute necrotizing ulcerative gingivitis
- Treatment with antibiotics within the 1-month period prior to beginning the study or any systemic condition which requires antibiotic coverage for routine periodontal procedures (e.g. heart conditions, joint replacements, etc) by report of the subject
- Known allergy to methylene blue
- Has glucose-6-phosphate dehydrogenase (G6PD) deficiency by subject report
- Currently uses anti-coagulant therapy at therapeutic doses
- Currently uses photosensitizing medications
- Participated in investigational treatment in the last 30 days or expectation for using a separate investigational treatment during the time of the study
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00297531
Start Date
April 1 2006
End Date
October 1 2007
Last Update
May 21 2007
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2N8
2
University of Western Ontario
London, Ontario, Canada, N6G 4L1
3
North York Dental Center
Toronto, Ontario, Canada
4
University of Saskatchewan
Saskatoon, Saskatchewan, Canada